DrugPatentWatch Database Preview
Try a free trial
See Plans and Pricing
« Back to Dashboard
Adderall Xr 30 is a drug marketed by Shire and is included in one NDA. There are four patents protecting this drug.
This drug has ten patent family members in eight countries.
The generic ingredient in ADDERALL XR 30 is amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. There are fifty-five drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate profile page.
Pharmacology for ADDERALL XR 30
Synonyms for ADDERALL XR 30
|24 HR Amphetamine aspartate|
|ADDERALL XR 10|
|ADDERALL XR 15|
|ADDERALL XR 20|
|ADDERALL XR 25|
|ADDERALL XR 5|
|Amphetamine aspartate mixture with amphetamine sulfate, dextroamphetamine saccharate and dextroamphetamine sulfate|
|Dextroamphetamine sulfate mixture with dextroamphetamine saccharate and amphetamine aspartate monohydrate and amphetamine sulfate|
|Country||Patent Number||Estimated Expiration|
|European Patent Office||1123087||Try a Free Trial|
|World Intellectual Property Organization (WIPO)||0023055||Try a Free Trial|
|Austria||427101||Try a Free Trial|
|Japan||2008303223||Try a Free Trial|
|>Country||>Patent Number||>Estimated Expiration|